|
KR20170044633A
|
|
Contorlled release formulation for the gastroretentive drug delivery system
|
|
KR20170069943A
|
|
Novel Solvates of Dapagliflozin or Methods for Preparing the Same
|
|
WO2017034377A1
|
|
Pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (kdms)
|
|
KR20170135420A
|
|
Novel Salts of Varenicline and methods for Preparing the same
|
|
WO2016171446A1
|
|
Stabilized pharmaceutical preparation containing peptide boronic acid compound
|
|
KR20160124681A
|
|
Pharmaceutical composition for stabilizing peptide boronic acid compound
|
|
WO2016117852A2
|
|
Method for preparing ticagrelor and novel intermediates therefor
|
|
KR20170055886A
|
|
Pharmaceutical preperation containing Bepotastine and Glyceryl Behenate
|
|
KR20170036352A
|
|
A composition for treating macular degeneration comprising a extract of Vaccinium Uliginosum as an active ingredient
|
|
KR20170033522A
|
|
A2E-BDP and screening method of inhibitors of intracelllular A2E accumulation or removers of intracellular A2E removal using the same
|
|
WO2016068453A1
|
|
Compound having gpr119 agonistic activity, method for preparing the same, and pharmaceutical composition including the same as effective component
|
|
CN105636946A
|
|
Method for preparing benzamide derivative, novel intermediate used in preparation of benzamide, and method for preparing novel intermediate
|
